Technology | November 17, 2008

Medtronic Gets CE Mark for MRI-Compatible Pacemaker

November 17, 2008 - Medtronic received European CE Mark for the EnRhythm MRI SureScan Pacemaker System, a pacemaker designed for safe use in Magnetic Resonance Imaging (MRI) systems.

The Medtronic EnRhythm MRI SureScan pacing system is reportedly the first pacemaker and lead system to be designed and tested in patients for safe use in MRI systems under specified conditions. Commercially available in Europe and under clinical evaluation in the U.S., the pacing system consists of the newly designed dual-chamber Medtronic EnRhythm MRI SureScan pacemaker and CapSureFix MRI SureScan pacing leads (Model 5086MRI).

Each year, approximately 1 million people worldwide are implanted with a pacemaker, hundreds of thousands of whom may be able to benefit from an MRI scan. A study published in Circulation shows that an MRI procedure is requested by a physician for 17 percent of pacemaker patients within 12 months of device implant. Every three minutes in the U.S. and every six minutes in Europe, a patient is denied an MRI scan due to the presence of an implantable cardiac device.

Medtronic believes that MRI safety and accessibility for people who have these devices remains a serious concern. To achieve true safety in an MRI environment, Medtronic believes that an entire system, including the pacemaker and leads, must be designed and rigorously tested for safe use with MRI scanners, and then approved by regulatory authorities for commercial use.

For more information: www.medtronic.com

Related Content

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement
News | Magnetic Resonance Imaging (MRI) | February 14, 2019
Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development...
FDA Clears Magnetom Lumina 3T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | January 30, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients
News | Magnetic Resonance Imaging (MRI) | September 17, 2018
Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Overlay Init